Article
Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
Genetics and molecular research : GMR - 31 Mar 2014
Jin Z Y, Zhao X T, Zhang L N, Wang Y, Yue W T, Xu S F
Abstract excerpt
This study aimed to investigate the effects of single-nucleotide polymorphisms (SNPs) XRCC1 Arg194Trp, XRCC1 Arg280His, XRCC1 Arg399Gln, XRCC3 Thr241Met, XPG His104Asp, and XPG His46His in genes involved in the DNA-repair pathway on the outcomes of platinum-based chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). The study period was from January 2005 to January 2006, and 378 NSCLC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
